New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
09:18 EDTDSW, PGEM, GALE, FST, ANFI, YGE, MDT, HIMX, NUAN, EXPE, QIWIOn The Fly: Pre-market Movers
HIGHER: Amira Nature Foods (ANFI), up 30% after Q4 results top expectations... DSW (DSW), up 2.6% after upgraded at Goldman... Yingli Green Energy (YGE), up 3.4% after reaffirming its FY14 PVmodule shipment target... Nuance (NUAN), up 3% after WSJ reported yesterday that the company is looking into potential sale, Oppenheimer estimates that Nuance could be sold for $25-$30... Medtronic (MDT), up 2.8% after upgrades at Morgan Stanley, Credit Suisse, and RBC Capital... Forest Oil (FST), up 15% after Sabine Oil & Gas denies $850M bridge financing facility was pulled... Galena (GALE), up 5% after completing enrollment in GALE-301 Phase 2a trial... Expedia (EXPE), up 2.6% following upgrade at Susquehanna. LOWER: Ply Gem (PGEM), down 5.8% after downgraded at Goldman... Himax (HIMX), down 4.4% after downgraded at UBS... QIWI (QIWI), down 3.6% after 7.973M share Secondary priced at $40.00.
News For DSW;EXPE;NUAN;HIMX;MDT;YGE;ANFI;FST;GALE;PGEM;QIWI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 14, 2014
08:17 EDTMDTCapricor Therapeutics to acquire certain patent rights from Medtronic
Capricor Therapeutics (CAPR) announced that it has entered into an agreement to acquire patent rights from Medtronic (MDT) relating to the formulation and pump delivery of natriuretic peptides. Capricor recently announced that it plans to develop a clinical program using Cenderitide, a natriuretic peptide, for the treatment of post-acute heart failure.
07:17 EDTGALEGalena receives notice of allowance of improvement patent for NeuVax in Japan
Galena Biopharma announced the notice of allowance from the Japanese Patent Office for NeuVax covering the use of NeuVax alone or in combination with other agents to prevent recurrence of any HER2/neu expressing breast cancer tumor having an immunohistochemistry level of 1+ or 2+, or a fluorescence in situ hybridization rating of less than about 2.0. NeuVax is a peptide immunotherapy for the prevention of cancer recurrence and is Galena's lead development agent in multiple ongoing and planned clinical trials. Once issued, the patent will expire in 2027, not including any patent term extensions.
06:42 EDTYGEPV modules with solar-grade wafers to account for 89% of capacity, DigiTimes says
Solarbuzz says solar photovoltaic modules using solar-grade wafers will account for 89% of solar capacity forecast to be installed in 2014, reports DigiTimes. Thin-filmed panel makers will supply nearly 8% of end-market demand in 2014, while premium cyrstalline silicon suppliers making up the remaining 3% share. Publicly traded companies in the space include Canadian Solar (CSIQ), First Solar (FSLR), JA Solar (JASO), SunPower (SPWR), Trina Solar (TSL), Panasonic (PCRFY) and Yingli Green Energy (YGE). Reference Link
October 13, 2014
10:00 EDTEXPEExpedia October calls active on renewed takeover chatter
Subscribe for More Information
09:46 EDTEXPERumor: Expedia moves up on renewed takeover chatter
Shares of Expedia are moving higher on takeover speculation emanating from the following link. Reference Link
09:22 EDTMDTMedtronic announces positive data from CoreValve ADVANCE DA Study
Subscribe for More Information
07:13 EDTMDTBioFlorida to hold a conference
Subscribe for More Information
October 12, 2014
17:55 EDTDSWWal-Mart, DSW could benefit from holiday sales, Barron's says
Wal-Mart (WMT) and DSW (DSW) could benefit from the recent forecast of a 4% increase in holiday spending, Barron's contends in a follow up article. Reference Link
October 10, 2014
07:04 EDTMDTMedtronic announces Omar Ishrak will remain CEO of new company
Subscribe for More Information
October 9, 2014
15:13 EDTEXPELiberty Media CEO says Diller not interested in sale of Expedia, Bloomberg says
Subscribe for More Information
14:48 EDTEXPELiberty Media CEO says discussed exiting Expedia stake, Bloomberg reports
Subscribe for More Information
October 8, 2014
18:31 EDTNUANOn The Fly: After Hours Movers
UP AFTER EARNINGS: Ruby Tuesday (RT), up 19.6%... Exar (EXAR), up 13.7% after reporting second quarter revenue guidance... Alcoa (AA), up 2.2%. ALSO HIGHER: Nuance (NUAN), up 2.5% following rumors that Carl Icahn will recommend that Apple (AAPL) buy the company... GrubHub (GRUB), up just under 1% after being initiated with a Buy at CRT Capital. DOWN AFTER EARNINGS: Kofax (KFX), down 20.1% after reporting first quarter revenue and fiscal 2015 revenue guidance below analyst estimates... ARC Group (ARCW), down 17%... E2open (EOPN), down 8.9%. ALSO LOWER: Gap (GPS), down 7.6% following September same store sales data and CEO transition... AMD (AMD), down 7% after announcing CEO transition.
16:26 EDTNUANOn The Fly: Closing Wrap
Subscribe for More Information
15:12 EDTNUANNuance October calls active amid speculation Icahn speculation
Subscribe for More Information
15:05 EDTNUANRumor: Nuance moves off lows amid Icahn speculation
Subscribe for More Information
09:30 EDTDSWDSW checks indicate improving comp trends, says Cleveland Research
Subscribe for More Information
09:23 EDTDSWCitigroup to hold a tour
Athletic Footwear Mall Tour travels to Roosevelt Field Mall, Garden City, New York on October 8.
07:09 EDTGALEGalena reports Notice of Allowance of U.S. patent application for NeuVax
Subscribe for More Information
October 7, 2014
10:17 EDTHIMXSamsung outlook miss weighs on suppliers
Subscribe for More Information
05:52 EDTHIMXStocks with implied volatility movement; S HIMX
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use